关于我们
MyRep is a secure, easy-to-use online platform designed to streamline your interactions with representatives and save you time. Here’s why over 200 companies and countless medical practices across the nation trust MyRep: ? Access the most up-to-date representative database in the industry. ? Set your calendar exactly how you choose, and let us handle the rest. ? Ensure that 99% of your available appointments get booked—with little to no effort on your part. ? Join offices that have switched from other solutions and are now delighted with MyRep’s efficiency and simplicity. Why wait? Join the growing MyRep community of medical practices and experience a hassle-free way to manage representative interactions. Let’s make scheduling simple together!
- 网站
-
https://myrepapp.com
MyRep的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 11-50 人
- 总部
- Clovis
- 类型
- 私人持股
- 创立
- 2020
- 领域
- Oncology、Community Practices、Hospitals、Scheduling Solutions、Dermatology、GI、Endocrinology、Nephrology、Neurology和Many More
地点
-
主要
获取路线
US，Clovis
动态
-
MyRep转发了
Dana-Farber’s Xin Zhou, PhD, devised a new platform for potential cancer therapy that destroys cancer-driving proteins. Learn more: https://bit.ly/48K0Rg4
-
MyRep转发了
The immunotherapy drug durvalumab (Imfinzi) can help people with early-stage small cell lung cancer live longer, results from a large clinical trial show. Three years after starting treatment, nearly 60% of people who received the drug were still alive. https://go.nih.gov/iKflyNG
-